Phycin Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $200K

  • Investors
  • 5

Phycin General Information

Description

Developer of a proprietary algal expression platform designed to modify algae cells into powerhouses. The company's platform employs technology to create transplastomic algal strains that express high levels of proteins of interest, enabling the life science industry to develop complex, animal component-free recombinant proteins that are safe and cost-effective.

Contact Information

Website
www.phycin.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4539 Metropolitan Court
  • Frederick, MD 21704
  • United States
+1 (443)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 4539 Metropolitan Court
  • Frederick, MD 21704
  • United States
+1 (443)

Phycin Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phycin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 11-Jul-2024 $200K Completed Generating Revenue
4. Grant 08-Jul-2024 Completed Generating Revenue
3. Seed Round 01-Jun-2023 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator 12-May-2015 Completed Generating Revenue
To view Phycin’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Phycin Patents

Phycin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250361278-A1 Recombinant production of growth factors in algae for cell culture applications Pending 24-May-2024

Phycin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phycin Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
TEDCO Venture Capital Minority
Maryland Stem Cell Research Fund Government
Opus8 PE/Buyout Minority
Maryland Innovation Center Accelerator/Incubator
Frederick Innovative Technology Center Accelerator/Incubator Minority
To view Phycin’s complete investors history, request access »

Phycin FAQs

  • When was Phycin founded?

    Phycin was founded in 2013.

  • Where is Phycin headquartered?

    Phycin is headquartered in Frederick, MD.

  • What is the size of Phycin?

    Phycin has 6 total employees.

  • What industry is Phycin in?

    Phycin’s primary industry is Biotechnology.

  • Is Phycin a private or public company?

    Phycin is a Private company.

  • What is Phycin’s current revenue?

    The current revenue for Phycin is .

  • How much funding has Phycin raised over time?

    Phycin has raised $200K.

  • Who are Phycin’s investors?

    TEDCO, Maryland Stem Cell Research Fund, Opus8, Maryland Innovation Center, and Frederick Innovative Technology Center have invested in Phycin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process